These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 7447399

  • 1. [Quality and stability of tetracycline tablets].
    Nesterova LIa, Grakovskaia LK, Shadyro LL, Okhotnikova VF.
    Antibiotiki; 1980 Nov; 25(11):828-31. PubMed ID: 7447399
    [Abstract] [Full Text] [Related]

  • 2. [Properties and stability of tetracycline hydrochloride tablets].
    Nesterova LIa, Donskaia NG, Shadyro LL, Grakovskaia LK.
    Antibiotiki; 1978 Jan; 23(1):62-6. PubMed ID: 623449
    [Abstract] [Full Text] [Related]

  • 3. [Effect of auxiliary substances on the bioavailability of tetracycline hydrochloride capsules (an in vitro study)].
    Grakovskaia LK, Nesterova LIa, Okhotnikova VF, Zak AF, Ermolova OB.
    Antibiotiki; 1978 Mar; 23(3):215-9. PubMed ID: 637528
    [Abstract] [Full Text] [Related]

  • 4. [Properties of tetracycline hydrochloride tablets and their bioavailability].
    Zak AF, Batuashvili TA, Loseva GI, Shatrova VM, Ermolova OB.
    Antibiotiki; 1980 Mar; 25(3):179-84. PubMed ID: 7362222
    [Abstract] [Full Text] [Related]

  • 5. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 3. Effect of lubricants.
    Asker A, el-Nakeeb M, Motawi M, el-Gindy N.
    Pharmazie; 1973 Jul; 28(7):476-8. PubMed ID: 4767501
    [No Abstract] [Full Text] [Related]

  • 6. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 2. Effect of disintegrants.
    Asker A, el-Nakeeb M, Motawi M, el-Gindy N.
    Pharmazie; 1973 Jul; 28(7):474-6. PubMed ID: 4767500
    [No Abstract] [Full Text] [Related]

  • 7. Development and evaluation of the tablets coated with the novel formulation termed thin-layer sugarless coated tablets.
    Ohmori S, Ohno Y, Makino T, Kashihara T.
    Int J Pharm; 2004 Jul 08; 278(2):459-69. PubMed ID: 15196649
    [Abstract] [Full Text] [Related]

  • 8. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D, Zheng W, Coots LB, McGinity JW.
    Eur J Pharm Biopharm; 2007 Sep 08; 67(2):464-75. PubMed ID: 17451929
    [Abstract] [Full Text] [Related]

  • 9. [Coating tablets with high molecular weight film-forming compounds. II. Obtaining a fast dissolving ethyl cellulose coating].
    Daragan AG.
    Aptechn Delo; 1966 Sep 08; 15(4):10-4. PubMed ID: 5990574
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of tetracycline base crystallization on the conditions properties of the powders and drug forms obtained. The development of directed crystallization procedures for tetracycline base].
    Lin'kov GI, Zhukovskaia SA.
    Antibiotiki; 1977 Aug 08; 22(8):678-83. PubMed ID: 20834
    [Abstract] [Full Text] [Related]

  • 11. [Effect of the crystallization conditions of tetracycline base on the properties of the powders and drug forms obtained. The dependence of the degree of dispersion of tetracycline base on the crystallization conditions].
    Lin'kov GI, Zhukovskaia SA, Dzhabarov DN, Nabokov VS.
    Antibiotiki; 1977 Sep 08; 22(9):841-6. PubMed ID: 20836
    [Abstract] [Full Text] [Related]

  • 12. [Use of polyvinylalcohol (PVA) in obtaining sugar-containing or sugar-free dragee coatings].
    Moldenhauer H, Kala H, Zessin G, Nauenburg G.
    Pharmazie; 1974 Jan 08; 29(1):26-31. PubMed ID: 4362359
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The coating of tablet surfaces by lubricants as determined by a film/tablet adhesion measurement.
    Rowe RC.
    Acta Pharm Suec; 1983 Jan 08; 20(1):77-80. PubMed ID: 6869027
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Kinetics of drug decomposition. III. Kinetics of decomposition of p-aminobenzoic acid and salicylamide in the presence of auxiliary tablet components].
    Pawełczyk E, Wachowiak R.
    Acta Pol Pharm; 1978 Jan 08; 35(4):433-9. PubMed ID: 707155
    [No Abstract] [Full Text] [Related]

  • 17. A novel white film for pharmaceutical coating formed by interaction of calcium lactate pentahydrate with hydroxypropyl methylcellulose.
    Sakata Y, Shiraishi S, Otsuka M.
    Int J Pharm; 2006 Jul 24; 317(2):120-6. PubMed ID: 16621357
    [Abstract] [Full Text] [Related]

  • 18. [Effect of selected binding substances and excipients on the properties of tablets containing beta-adrenolytic drugs].
    Szlaski J, Zakrzewski Z.
    Acta Pol Pharm; 1981 Jul 24; 38(3):351-7. PubMed ID: 6119004
    [No Abstract] [Full Text] [Related]

  • 19. [Influence of adjuvants on the dissolution rate and stability of acetylsalicylic acid in tablets. II. Effect of lubrication agents].
    Cid E, Jaminet F.
    J Pharm Belg; 1971 Jul 24; 26(4):360-8. PubMed ID: 5142947
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of composition of pharmaceutic aids on the disintegration of tablets].
    Borzunov EE, Shevchenko SM.
    Farmatsiia; 1969 Jul 24; 18(1):20-3. PubMed ID: 5770765
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.